Growth Metrics

Nexalin Technology (NXL) Operating Expenses (2021 - 2025)

Nexalin Technology (NXL) has 5 years of Operating Expenses data on record, last reported at $2.4 million in Q3 2025.

  • For Q3 2025, Operating Expenses fell 6.79% year-over-year to $2.4 million; the TTM value through Sep 2025 reached $9.0 million, up 35.15%, while the annual FY2024 figure was $7.9 million, 36.42% up from the prior year.
  • Operating Expenses reached $2.4 million in Q3 2025 per NXL's latest filing, up from $1.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $2.9 million in Q4 2024 and bottomed at $602494.0 in Q4 2021.
  • Average Operating Expenses over 5 years is $1.5 million, with a median of $1.3 million recorded in 2024.
  • Peak YoY movement for Operating Expenses: tumbled 59.84% in 2022, then soared 274.02% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $602494.0 in 2021, then rose by 24.68% to $751174.0 in 2022, then surged by 118.3% to $1.6 million in 2023, then soared by 76.55% to $2.9 million in 2024, then fell by 18.49% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $2.4 million in Q3 2025, $1.7 million in Q2 2025, and $2.0 million in Q1 2025.